Cyberonics, Inc. (Nasdaq: CYBX) today announced that the United States Food and Drug Administration (FDA)approved the Vagus Nerve Stimulation (VNS) Therapy System “for the adjunctivelong-term treatment of chronic or recurrent depression for patients 18 yearsof age or older who are experiencing a major depressive episode and have nothad an adequate response to four or more adequate antidepressant treatments… click link for more info.
Popularity: unranked [?]
